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Background. Human papillomavirus (HPV) has been implicated 
as one of the principal causes of cervical cancer, which is the 
second highest cause of cancer deaths among Nigerian women. 
Objective. This study was aimed at determining the presence of 
HPV DNA in abnormal cervical cytology of a group of women 
who were screened using Papanicolaou staining technique.
Methodology. A total of 200 women attending the Obstetrics and 
Gynaecology clinic of the Federal Teaching Hospital, Ido-Ekiti, 
were screened by means of conventional Pap smear screening, 
while positive samples underwent molecular analyses by means of 
DNA isolation techniques and polymerase chain reaction (PCR). 
Result. Results revealed that 14 (7%) of the subjects were positive 
for abnormal cytology. Abnormalities found among the subjects 
included: low-grade squamous intraepithelial lesions (LSIL), 
which constituted 50% of the total abnormal smears, high-grade 
squamous intraepithelial lesion (HSIL) and atypical squamous 
cells of undetermined significance (ASCUS), which were 28.6% 
and 21.4%, respectively. Molecular analyses showed that all the 
samples from abnormal cervical cytology subjected to HPV DNA 
extraction and gene amplification contained HPV DNA. 
Conclusions. The high prevalence of HPV DNA in abnormal 
cytology gives credence to the fact that the presence of HPV is 
a critical indicator of the development of cervical cancer. Thus 
more effort should be put into vaccine production and distribution 
in order to reduce the incidence of cervical cancer in Nigeria. 
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Summary
Introduction
Human papillomavirus (HPV) belongs to the family 
Papillomaviridae, which is capable of infecting humans. 
Like all papillomaviruses, HPV establishes productive 
infection only in keratinocytes of the skin or mucous 
membranes [1]. HPV is a small non-enveloped icosahe-
dral DNA virus that replicates  in the nucleus of squa-
mous epithelial cells  [2]. High-risk human papilloma-
viruses (HR-HPVs) are able to infect several types of 
epithelial cells, but more frequently cause cancer in the 
uterine cervix [3].
Various risk factors are associated with the occurrence 
of HPV infection; these include: smoking, multiparity, 
early onset of sexual intercourse, oral contraceptive use 
and Human Immunodeficiency Virus. They contribute 
greatly to an individual’s chances of developing cervi-
cal cancer [4]. Cervical cancer ranks as the second most 
frequent cancer among women in Nigeria, and the most 
frequent cancer among women between 15 and 44 years 
of age. About 23.7% of women in the general popula-
tion are estimated to harbor cervical HPV infection at 
any given time  [1]. The prevalence of HPV genotypes 
in cervical cytological samples varies greatly in differ-
ent geographical regions and shows a strong correlation 
with cervical cancer incidence. Epidemiological studies 
have consistently shown that the most important deter-
minants of HPV infection in women are the number of 
sexual partners, the age of initiation of sexual activity, 
and the sexual behaviour of the male partner [5].
Clifford et al. randomly selected women from 11 coun-
tries for HPV DNA testing, using GP5+/6+ PCR anal-
yses  [6]. Women aged 15-74  years who did not have 
cytological abnormalities were included (n  =  15613). 
They found that age-standardized prevalence varied 
nearly 20-fold among different populations: from 1.4% 
in Spain, to 25.6% in Nigeria. Overall, age-standardized 
HPV prevalence was five times higher in sub-Saharan 
Africa than in Europe, with intermediate prevalence in 
South America and Asia. In terms of types, HPV type 
16 was the commonest type in all regions except sub-Sa-
haran Africa, where HPV type 35 was equally common. 
Materials and methods
Ido-Ekiti is located in Ido/Osi Local Government Area 
of Ekiti State, Nigeria. It is situated in the Northern part 
of the state, where the routes from Oyo, Osun and Kwara 
states converge. Ido-Ekiti is the headquarters of Ido/Osi 
local council. The hospital is located in Ido-Osi Local 
Government Area of Ekiti State, which lies south of 
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Kwara and Kogi State, East of Osun State and north of 
Ondo State, and has a total land area of 5887.890 sq km. 
The 2006 population census by the National Popula-
tion Commission put the population of Ekiti State at 
2,384.212 people.
Study population
The study was carried out among women attending the 
Gynaecology Clinic of the Federal Teaching Hospital, 
Ido-Ekiti who were between the ages of 15-64  years, 
willing to participate and met the inclusion criteria. A 
structured close-ended questionnaire was administered 
to these patients after informed consent had been ob-
tained, followed by clinical examination.
Inclusion criteria
Female patients attending the Obstetrics and Gynaeco-
logical unit, between 15 to 64 years of age, who con-
sented to take part in the study, and non-patients who 
met other inclusion criteria and agreed to participate in 
the study.
Exclusion criteria
Female patients over 65 years or under 15 years; male 
patients; patients who do not give consent to take part 
in the study and patients who have had total abdominal 
hysterectomy.
Ethical clearance
Approval for this study was obtained from the Ethics 
Review Committee of the Federal Teaching Hospital, 
Ido-Ekiti, after which informed consent was obtained 
from patients and/or parents and guardians. The study 
was done at no financial cost to the subjects, and infor-
mation from the patients and/or parents and guardians 
were confidential.
Sample collection and analysis
A structured close-ended questionnaire was admin-
istered to the subjects after due consent had been ob-
tained; cervical smears were collected by a gynaecolo-
gist after visual inspection. The smears collected were 
immediately fixed to slides before being transferred to 
the laboratory for processing. The fixed smears were 
stained by the cytotechnologist using the Papanicolaou 
staining procedure and read by a histopathologist using a 
light microscope. The smears were classified as normal, 
inflammatory, abnormal (epithelial lesion) or unsatisfac-
tory. 
Data Analysis
Descriptive statistics (mean, frequency, standard devia-
tion and percentage) and a graph were used to present 
the results, in order to provide a clear representation of 
the data analyzed. The statistical package for social sci-
ence version 17.0 for windows was used to test for the 
level of significance of the results obtained. Both con-
tinuous and discrete variables were generated. The rela-
tionship between categorical variables and outcome of 
interest was tested by means of Chi-square test at 95% 
(p < 0.05) confidence interval.
PCR/DNA extraction 
Molecular analyses began with the extraction of DNA 
from the cervical smears that were positive for intraepi-
thelial neoplasia. The coverslips present on the slides 
during Pap staining were removed with the aid of xy-
lene, and the smears carefully removed by means of 
sterile scapel blades. A DNA extraction kit produced 
by Integrated DNA Technologies, USA, was utilized 
for DNA extraction. The extracted smears were trans-
ferred to 1.5ml tubes for DNA extraction. Buffy coats 
and proteinase K were used to lyse the cells of the virus, 
and DNA extraction was done by means of chloroform. 
PCR components were produced by Integrated DNA 
technologies (USA); the PCR reaction contained prim-
ers Gp5: 5’TTTGTTACTGTGGTAGATACTAC-3’and 
Gp6: 5’GAAAAATAAACTGTAAATCATATTC-3’. 
The reaction was programmed as follows. Initial dena-
turing step at 95°C for 15 min, 10 cycles of 30s at 94°C, 
90s at 72°C, followed by 30 cycles of 30s at 94°C, 90s 
at 63°C and 90s at 72°C, with a final extension of 72°C 
for 10 min. A DNA band of 150 kb was considered a 
positive result.
Gel electrophoresis procedure
Agarose (3g) was heated in solution in a microwave un-
til it had completely dissolved, and was then allowed to 
cool in a water bath set at 50-55°C. The required num-
bers of combs were placed in the gel tray; 5 ul of eth-
idium bromide was added to the cooled gel, which was 
then poured into the gel tray. The gel was allowed to cool 
for 15-30 min at room temperature. The combs were re-
moved and placed in an electrophoresis chamber and 
covered with buffer (TAE). DNA and standard (ladder) 
was loaded onto the gel, which was electrophoresed for 
at least an hour. DNA bands were visualized by means 
of a gel imaging system.
Results
Table I shows the socio-demographic and reproductive 
characteristics of the respondents; about two-thirds 133 
(66.5%) of the women had attained their sexual debut 
at ≤ 15 years of age. Married women accounted for 176 
(88.0%), and 146 (73%) had a tertiary education.
Figure 1 shows the distribution of the abnormal cervical 
cytology by type of abnormality. Three different types of 
abnormality were found among the subjects. Low-grade 
squamous intraepithelial lesions (LSIL) constituted the 
main form of abnormal cytology, accounting for 50% 
of the total abnormal smears. High-grade squamous in-
traepithelial lesions (HSIL) were 28.6%, while atypical 
squamous cells of undetermined significance (ASCUS) 
were 21.4%.
All the samples presenting abnormal cervical cytology 
underwent HPV DNA extraction and gene amplification; 
all contained HPV DNA (Fig.  2). Fourteen abnormal 
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Fig. 1. Distribution of abnormal cervical cytology types amongst subjects in relation to acquisition of HPV infection.
Tab. I. Socio-demographic and reproductive characteristics of the respondents.
Variables Frequency (%) Variables  Frequency (%) N = 200
Age (years) Age at sexual debut (years)
15-24 5 (2.5) ≤ 15 133 (66.5)
25-34 50 (25.0) > 15 67 (33.5)
35-44 80 (40.0)
45-54 47 (23.5) Parity
55-64 18 (9.0) 0 45 (22.5)
1-3 116 (58.0)
> 3 39 (19.5)
Level of education
Primary 4 (2.0) Previous genital infection
Secondary 23 (11.5) Yes 126 (73.0)
Tertiary 146 (73.0) No 74 (37.0)
None 27 (13.5)
Marital status Number of sexual partners
Single 19 (9.5) 0-1 174 (87.0)
Married 176 (88.0) > 1 26 (13.0)
Divorce 5 (2.5)
Alcohol intake Male partner circumcision
Yes 31 (15.5) Yes 192 (96.0)
No 169 (84.5) No 8 (4.0)
Tobacco use
Yes 9 (4.5)
No 191 (95.5)
Type of marriage**
Monogamy 57 (31.5)
Polygamy 124 (68.5)
Use of oral contraceptives
Yes 111 (55.5)
No 89 (44.5)
** N=181
ASCUS: Atypical cells of uncertain 
significance
LSIL: Low-grade squamous 
intraepithelial lesion
HSIL: High-grade squamous 
intraepithelial lesion
MOLECULAR DETECTION OF HPV DNA IN CERVICAL SMEARS
E89
cervical cytology samples underwent molecular studies. 
Of these 14 samples, 7 had low-grade squamous intraep-
ithelial lesions, 4 were high-grade squamous intraepithe-
lial lesions and the remaining 3 atypical squamous cells 
of uncertain significance. The molecular results showed 
the analysis of HPV DNA in cervical samples to be a 
predictor of seropositivity. The 1-14 bands indicated in 
the gel electrophoresis image (1-14) are indicative of 
the presence of HPV DNA. Lane 1 represents (M) High 
ranger 1kb DNA Ladder; lanes 2-15 are amplified HPV 
genome: 1,2,3,4,5,6,7,8,9,10,11,12,13,14, and lane  16 
shows a negative control (NC).
Discussion
Results showed that the largest number of abnormal smears 
were of low-grade squamous cell carcinoma (LSIL), which 
accounted for about 50% of abnormalities. This is similar 
to the results obtained by Obaseki and Nwafor (2013), 
who reported that LSIL accounted for the highest percent-
age (66.27%) of abnormalities found [7]. 
In this study, HPV DNA was extracted from all the sam-
ples with abnormal cytology; all of the subjects with ab-
normal cervical cytology were also positive for the pres-
ence of HPV DNA. This is in line with the results of the 
study by Sharifah et al. (2009), in which all 38 abnormal 
cervical cytology smears analysed were positive for the 
presence of HPV DNA [8]. HPV DNA was discovered in 
all the cases of low-grade quamous cell carcinoma, high-
grade squamous cell carcinoma and atypical squamous 
cells of uncertain significance. This high prevalence of 
HPV DNA in abnormal cytology observed in this study 
also lends credence to several studies which have cast 
doubt on the existence of HPV DNA-negative abnormal 
cervical smears [8]. Indeed, various studies have shown 
a high prevalence of HPV DNA in abnormal cytology; 
this is in agreement with the presence of HPV DNA in 
all our abnormal cervical smears [4]. The frequency of 
HPV in abnormal cervical cytology also underlines the 
strong correlation between cervical cancer, HPV DNA 
positivity and abnormal cervical cytology.
Even though genotyping could not be done in this study, 
the presence of HPV DNA in all abnormal cervical 
smears reveals a dire need for a national program
 for vaccination against HPV infection in Nigeria. There 
is also a need to look at the various screening methods 
utilized for detecting HPV infection and, where possi-
ble, molecular techniques should be incorporated along-
side with serology and the Papanicolaou test. 
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